Gossamer Bio Inc [GOSS] stock prices are down -4.14% to $2.55 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GOSS shares have gain 5.81% over the last week, with a monthly amount drifted -29.17%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Gossamer Bio Inc [NASDAQ: GOSS] stock has seen the most recent analyst activity on September 10, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $9 for it. Previously, Scotiabank started tracking the stock with Sector Outperform rating on July 14, 2025, and set its price target to $11. On June 25, 2024, Oppenheimer initiated with an Outtperform rating and assigned a price target of $9 on the stock. UBS downgraded its rating to a Neutral and reduced its price target to $1.25 on July 27, 2023. Raymond James downgraded its rating to Mkt Perform for this stock on March 07, 2023. In a note dated March 01, 2023, Guggenheim initiated a Neutral rating.
The stock price of Gossamer Bio Inc [GOSS] has been fluctuating between $0.76 and $3.87 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Gossamer Bio Inc [NASDAQ: GOSS] shares were valued at $2.55 at the most recent close of the market. An investor can expect a potential return of 252.94% based on the average GOSS price forecast.
Analyzing the GOSS fundamentals
The Gossamer Bio Inc [NASDAQ:GOSS] reported sales of 44.05M for trailing twelve months, representing a surge of 40.23%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -3.65%, Pretax Profit Margin comes in at -3.6%, and Net Profit Margin reading is -3.55%. To continue investigating profitability, this company’s Return on Assets is posted at -0.75, Equity is 5.94 and Total Capital is -1.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -2.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Gossamer Bio Inc [NASDAQ:GOSS]’s Current Ratio is 3.28. Also, the Quick Ratio is 3.28, while the Cash Ratio stands at 0.14. Considering the valuation of this stock, the price to sales ratio is 13.40.
Transactions by insiders
Recent insider trading involved Milligan Sandra, Director, that happened on Aug 19 ’25 when 26050.0 shares were purchased.
